• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Lemtrada

Pharma

NICE gives a thumbs-down to Bristol Myers' MS newcomer Zeposia

NICE said it struggled to see how the benefits of Zeposia justify its cost, citing a lack of data comparing it to rival MS drugs like Roche’s Ocrevus.
Arlene Weintraub Jan 22, 2021 11:21am

Sanofi ponies up $315M to settle Lemtrada milestone spat

Nov 4, 2019 10:30am

Sanofi's Lemtrada goes under EU review for fatal side effects

Apr 15, 2019 11:35am

Merck KGaA finally chalks up FDA nod for MS med Mavenclad

Apr 1, 2019 10:20am

FDA hits Sanofi's struggling Lemtrada with new safety warning

Nov 30, 2018 10:48am

Can Sanofi's new long-term Lemtrada data amp up MS sales?

Oct 11, 2018 9:59am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy